Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases
about
The spectrum of disease in chronic traumatic encephalopathyTargeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueHijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearanceInsoluble cellular prion protein and its association with prion and Alzheimer diseasesInteraction between prion protein and Aβ amyloid fibrils revisitedCross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseasesGenesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion diseaseNovel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's diseaseGenetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative DiseasesEarly-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.Prion strain interactions are highly selective.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assayβ-amyloid oligomers and prion protein: Fatal attraction?Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neuronsHuman Microbiome and its Association With Health and Diseases.High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide.Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic mice.Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders.Traumatic brain injury may increase risk of young onset dementiaPromiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms.Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's diseaseBacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequencesExploring the basis of [PIN(+)] variant differences in [PSI(+)] inductionThe cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.Cell-to-cell transmission of non-prion protein aggregates.Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structureVariant-specific prion interactions: Complicating factors.The amyloid interactome: Exploring protein aggregation.Interaction between pathogenic proteins in neurodegenerative disorders.The amyloid state of proteins in human diseases.Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory.Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease.Prion protein oligomer and its neurotoxicity.Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.Prion protein and aging.
P2860
Q22242925-3C1A2DF9-54DD-4627-B906-C3C65E4A6B74Q26852041-0B34EC93-23A6-4754-8365-AAF4A48A5D5DQ27009790-8EA6F11B-F4CB-451E-B1C5-C1CFDF9A588DQ27012706-8673DC4F-2044-4890-BBBA-2989BBF72244Q27013909-6F99A798-2263-4418-A70E-FE534EF171C4Q27021846-A6F4E799-9FB3-47A4-A917-EAAB6CB0AE9DQ27348022-93DEF845-91F2-458C-A4AD-39043495C09BQ28535011-71B5A38B-7084-4093-B1C2-3233E98DC40EQ31026808-BFF8214B-E9D6-44DA-AD21-6F9D71DC0B83Q33679220-01E2A293-8E55-4852-B330-13774A87BFFEQ33793048-7D490F86-4807-45B2-8B36-5D5E6B4004BFQ34171325-DF82B1E0-F968-4C7D-888E-C5885587526EQ34185289-15E0A292-72EE-4703-93C9-C2A4EFB03950Q34193337-C4112804-52B7-4664-87E1-DD7646230D7FQ34362517-0C6F1E0D-016E-40DB-B460-1282A8BCA860Q34570035-4488EE45-BC69-474E-AFD5-55A06D37EF2EQ34868772-BC7FA6EB-EE94-47D7-B675-FAA46DE01D8AQ35863939-72F50AA2-FEAB-4A6E-ACA4-0D41F89594DCQ35867582-F5A4C83C-E2A6-4281-B0C8-3E90F3F89F61Q35974386-A19975FD-DE75-48E9-81CA-C674A6E4AE0DQ36005171-37E410B5-1EC7-437E-A2C3-EE3B134B3E39Q36060992-535AF888-0B26-45C2-A1BE-A98E40B097C1Q36207519-CE3E99F7-8459-46B0-9A01-2B84E2227A62Q36318763-B75BA8A0-38E9-4A92-9C6E-5E62F2D001E2Q36483911-B8D6327B-56FE-480C-9439-1A3F172B925DQ36774319-22A95B63-E7AD-4E3F-84FF-091F5B04D233Q37096279-CBAE2118-D8B5-462C-A74A-E25869603949Q37157714-D94DCCD4-75DD-472A-A211-D0BF56892FE8Q37200740-FFDC9029-0D92-43D4-91EE-602F8F935964Q37434134-5D868591-FA26-4A09-8657-31BE2D264216Q37478512-E235E5B7-D73C-4D0E-A741-83CEE7E4F901Q37739930-2606A457-B6B9-4E21-8F8E-24C5E0A60C3BQ37969262-8265B597-2F17-481B-8C31-0C329772417CQ37994283-7D20FC32-4315-4B31-90A0-C231CDEDF776Q38026984-552537B5-A5CE-494E-9517-48F9C9390D32Q38069821-FC5BAC47-A8A5-4279-96FC-AC9DE4AF2F59Q38096098-851E093B-566A-4C63-B7F3-B48269EFEAAFQ38132099-1A1EEEFC-2A98-44A8-83E2-9A5B6AD9D140Q38171006-0D34DA2B-D880-4ED6-A236-D03500A49D4EQ38264466-82E52932-6E2E-47AE-AFAF-7ACBBD09628B
P2860
Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular cross talk between m ...... Alzheimer's and prion diseases
@ast
Molecular cross talk between m ...... Alzheimer's and prion diseases
@en
Molecular cross talk between m ...... Alzheimer's and prion diseases
@nl
type
label
Molecular cross talk between m ...... Alzheimer's and prion diseases
@ast
Molecular cross talk between m ...... Alzheimer's and prion diseases
@en
Molecular cross talk between m ...... Alzheimer's and prion diseases
@nl
prefLabel
Molecular cross talk between m ...... Alzheimer's and prion diseases
@ast
Molecular cross talk between m ...... Alzheimer's and prion diseases
@en
Molecular cross talk between m ...... Alzheimer's and prion diseases
@nl
P2093
P2860
P3181
P1476
Molecular cross talk between m ...... Alzheimer's and prion diseases
@en
P2093
Claudio Soto
Diego Morales-Scheihing
Joaquin Castilla
Lisbell D Estrada
Maria C Jara
Rodrigo Diaz-Espinoza
Rodrigo Morales
P2860
P304
P3181
P356
10.1523/JNEUROSCI.5924-09.2010
P407
P577
2010-03-31T00:00:00Z